Advertisement
Research Article Free access | 10.1172/JCI112045
Find articles by McDougal, J. in: JCI | PubMed | Google Scholar
Find articles by Martin, L. in: JCI | PubMed | Google Scholar
Find articles by Cort, S. in: JCI | PubMed | Google Scholar
Find articles by Mozen, M. in: JCI | PubMed | Google Scholar
Find articles by Heldebrant, C. in: JCI | PubMed | Google Scholar
Find articles by Evatt, B. in: JCI | PubMed | Google Scholar
Published August 1, 1985 - More info
The virus that causes the acquired immunodeficiency syndrome (AIDS), human T lymphotropic virus/lymphadenopathy-associated virus (HTLV-III/LAV), was incubated at temperatures from 37 degrees to 60 degrees C and virus titer (ID-50) was determined over time by a microculture infectivity assay. The rate of thermal decay was consistent with first-order kinetics, and these data were used to construct a linear Arrhenius plot (r = 0.99), which was used to determine inactivation time as a function of temperature. In the liquid state, thermal decay was little affected by matrix (culture media, serum, or liquid Factor VIII). In the lyophilized state, the time required to reduce virus titer 10-fold (1 log) at 60 degrees C was 32 min compared with 24 s in the liquid state. HTLV-III/LAV in liquid antihemophilic Factor VIII or IX was lyophilized and heated according to commercial manufacturers' specifications. Infectious virus was undetectable with these regimens. Heat treatment should reduce or stop transmission of HTLV-III/LAV by commercial antihemophilic Factor VIII or IX.
Click on an image below to see the page. View PDF of the complete article